Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...

Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...

Polyrizon (PLRZ) previously announced the initiation of preclinical studies for intranasal Naloxone, a life-saving opioid overdose treatment.

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Check a company’s competitiveness in the job market with alternative data that tracks hiring, job openings, and more.

Xylo's affiliations in the medical solutions arena include ownership in Polyrizon Ltd. The Company's affiliates in digital commerce include Gix Internet Ltd. and Eventer Technologies Ltd. In the ...

Polyrizon Ltd. (NASDAQ:POLY), a biopharmaceutical company, announced today the appointment of Liron Carmel to its Board of Directors, effective immediately. Mr. Carmel, who brings a wealth of ...

(RTTNews) - Polyrizon Ltd. (PLRZ), a development-stage biotech company, has filed a divisional patent application with the Israel Patent Office for its Trap & Target or T&T intranasal drug ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...